Like every month PharmaShots was occupied following the trail of biopharma updates across the globe. PharmaShots as an official media partner to Reuters Events Pharma USA 2024 was physically present covering the groundbreaking presentations of biopharma companies.  

Our most-read Top 20 Report was dedicated to Women health Focussing Companies & IPOs by Total Fund Value. In the Top-Performing Drug Edition we covered Invega Trinza. The Know Your Investor Report featured Qiming Venture Partners. To honor Alport Syndrome Awareness Month, we prepared a condensed report on Alport Syndrome for our Disease of the Month Report. 

As promised to our audiences, we published A Complete Account of EMA approvals in 2023. PharmaShots, like every month, published reports on the FDA approvals, EMA approvals, biosimilars, & New drug Designations to keep our audiences up to date on the developments in the biopharma industry. 

In a world driven by innovations and digital trends, Telehealth needs no introduction. Yes, the theme for our April Magazine revolves around Telehealth. Telehealth is not just confined to seeking healthcare services remotely using digital technologies but also caters to managing your health care, making it a more diverse and broad term that includes telemedicine and mHealth among others.

Want to advertise in PharmaShots Magazine for FREE? Email us at connect@pharmashots.com